What was very telling to me about the video was the fact

New Post Public Reply Private Reply Replies (1) Message Board
matzaball redspeed #19482
499
What was very telling to me about the video was the fact that while in the midst of 300% growth for the year for IDLife, which she admitted was extremely hard to handle, they still decided to add on Verb's app and sampling three months ago. One would think that would be a major challenge to take on a new application and train their force to use it in midst of trying to manufacture product, get it our the door, keep customers happy, in the middle of a pandemic no less. But realistically, the new technology they employed from Verb made things easier for them. No more need for "belly to belly" and it enabled them to consolidate communications and make them more uniform from one sales associate to the next.

Not only that, but her raving about how Verb's new sampling feature revolutionizes the process was outstanding!

The app and corresponding add on products from Verb simplify transactions and communications with current and prospective clients. Proof positive, directly from a customer's mouth.

If that was not one of the best advertisements for Verb, I don't know what is.

Beyond Verb Live, next up, Small Biz Tool that enables businesses outside the Direct Sale World to have a similar app and add on features (as mentioned in the Japan press release).

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 45

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Green Leaders: 2024 IGIHOF Induction Ceremony Details

Updated Category News Views 276

Celebrating the Newest Inductees into the Green Industry The International Green Industry Hall of Fame (IGIHOF) is gearing up for its annual induction ceremony, where it will honor nine remarkable individuals and organizations dedicated to advancing ecological sustainability. This year, the event will take place within the environment of innovative learning at the...

Continue Reading
Governor Advocates for Controlled Substances Decriminalization

Updated Category News Views 48

Governor Advocates for Controlled Substances Decriminalization Puerto Rico’s Governor Pedro Pierluisi Urrutia has made a compelling argument for decriminalizing the consumption of all controlled substances. His stance primarily addresses the pressing fentanyl crisis affecting communities across the island. Governor Pierluisi highlighted, "I have said since the 90s that...

Continue Reading
Odyssey Marine Exploration: Navigating Stock Market Challenges

Updated Category News Views 221

Recent Trends in Odyssey Marine Exploration Stock Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) has seen its stock price fluctuate significantly in recent times. After an arbitration award involving the company and the United Mexican States was announced, the stock experienced a sharp decline, which has sparked concerns about its future path. Decoding the Arbitration...

Continue Reading
Decent Holding Inc. Unveils US$8 Million Offering for Growth

Updated Category News Views 101

Decent Holding Inc. Announced Its New Offering In a significant move within the wastewater treatment sector, Decent Holding Inc. (NASDAQ: DXST) shared exciting news about their latest financing initiative. The company has introduced a registered offering amounting to US$8 million. This offering involves 13,333,333 Class A ordinary shares priced at US$0.60 each, along with...

Continue Reading
Nexxen Strengthens Data Strategies with Eric Solomon's Leadership

Updated Category News Views 208

Nexxen Appoints Eric Solomon to Drive Data Strategy In a significant move for the advertising technology landscape, Nexxen (NASDAQ: NEXN) has welcomed Eric Solomon as its new Senior Vice President for Product – Data. This appointment underscores Nexxen's dedication to a data-driven approach that aims to enhance growth and success for advertisers and media companies...

Continue Reading